Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT Patch Immunogenicity and Safety
NCT00672035Phase 2Completed
- Sponsor
- Intercell AG
- Start
- Oct 2006
- Primary completion
- Dec 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of travellers' diarrhoea vaccine patch in traveler's diarrhea (TD), sponsored by Intercell AG. Started Oct 2006; status: completed.
02
Drugs
travellers' diarrhoea vaccine patch
03
Conditions
traveler's diarrhea (TD)
Beyond the preview
Go deeper on NCT00672035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00672035.